Clinical Trial Update: Efficacy and Safety of Lu AA34893 in Patients With Bipolar Depression [Phase 2]

View source ↗

Summary

Phase 2 trial of Lu AA34893 for bipolar depression was terminated; the document summarizes study efficacy and safety considerations.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bipolar Disorder

Drugs mentioned

• Lu AA34893

Snippet

Sponsor: H. Lundbeck A/S | Conditions: Depression in Patients With Bipolar Disorder | Phase 2 | Status: TERMINATED